RC
GILD icon

Rexford Capital’s Gilead Sciences GILD Stock Holding History

Rexford Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$899K Buy
6,452
+103
+2% +$14.4K 0.64% 48
2025
Q4 		$779K Hold
6,349
– – 0.59% 51
2025
Q3 		$705K Buy
6,349
+70
+1% +$7.96K 0.55% 54
2025
Q2 		$696K Buy
+6,279
New +$668K 0.58% 54

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Rexford Capital's GILD Position: Q1 2026 in Review

Rexford Capital increased its Gilead Sciences (GILD) stake by 1.6% in Q1 2026, buying an estimated $14.4K and bringing the position to 6,452 shares worth $899K. The position accounts for 0.64% of the portfolio, ranked #48.

Rexford Capital first reported a position in GILD in Q2 2025 and has held it in 4 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Rexford Capital held 6,452 shares of Gilead Sciences worth $899K as of Q1 2026.
  • Rexford Capital bought 103 Gilead Sciences shares in Q1 2026, an estimated $14.4K.
  • Gilead Sciences made up 0.64% of Rexford Capital's portfolio in Q1 2026, its #48 holding.
  • Rexford Capital first reported a position in Gilead Sciences in Q2 2025 and has held it in 4 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Rexford Capital's 13F filing for Q1 2026, filed 24 Apr 2026.